Results
1 -
10 of
48Therapeutic options for herpes simplex infections, Current Infectious Disease Reports Biological Response Modifier in Cancer Immunotherapy, Progress in Cancer Immunotherapy TLR Agonists as Vaccine Adjuvants, Innovation in Vaccinology TLR Agonists as Adjuvants for Cancer Vaccines, Regulation of Inflammatory Signaling in Health and Disease Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model, BMC Cancer Use of Primary Human Cells in High-Throughput Screens, High Throughput Screening Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy, Cancer Immunology, Immunotherapy Imiquimod: The biochemical mechanisms of immunomodulatory and anti-inflammatory activity, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry Modulation of innate immunity in the tumor microenvironment, Cancer Immunology, Immunotherapy Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine, Archives of Virology